In this editorial, Rupert Payne, Consultant Editor for Prescriber, discusses the current barriers around antibiotic development alongside the important advances in chemistry, molecular biology, genetics and bioinformatics that may all contribute to the development of new antimicrobials.
Articles: 29.10 October 2018
Artificial intelligence (AI) is already beginning to transform many aspects of healthcare, from offering advice to interpreting scans. This article discusses the progress that has been made so far and the AI-based applications we are likely to see in the near future
Despite reductions in overall case numbers both globally and in the UK, tuberculosis (TB) remains a major health problem. Here, the authors discuss the pathogenesis of TB and important aspects of management, alongside recent developments in epidemiology, diagnostics and treatment
In March, NICE updated its guidance on the diagnosis and management of attention deficit hyperactivity disorder (ADHD) for the first time in 10 years. This article provides a summary of the new guideline’s main recommendations
Delays in the diagnosis of autism spectrum disorder (ASD) in children and young people are all too common and cause real anguish for those affected and their families. This article assesses the scale of the problem and discusses possible reasons and solutions
OpenPrescribing is an online service launched in 2016 that facilitates the analysis of NHS primary care prescribing data in order to improve the quality and cost-effectiveness of prescribing. In this article, Joy Ogden talks to its founders Dr Ben Goldacre and Dr Peter Brindle about what the service has achieved since its launch, and their plans for its future development
Benralizumab (Fasenra) is a new anti-interleukin-5 monoclonal antibody therapy for the management of severe uncontrolled eosinophilic asthma. This article discusses its properties, clinical trial efficacy and adverse effects